cannabidiol (CHI-554)
/ Canopy Growth
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
August 01, 2024
Safety of Co-Administered CHI-554 and Alcohol
(clinicaltrials.gov)
- P1 | N=29 | Completed | Sponsor: Auburn University | Recruiting ➔ Completed
Trial completion
December 16, 2022
Safety of Co-Administered CHI-554 and Alcohol
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Canopy Growth Corporation | Trial completion date: Dec 2022 ➔ Mar 2023 | Trial primary completion date: Dec 2022 ➔ Mar 2023
Trial completion date • Trial primary completion date
September 23, 2022
CBD in Postmenopausal Women With Osteopenia
(clinicaltrials.gov)
- P1 | N=2 | Terminated | Sponsor: Canopy Growth Corporation | Active, not recruiting ➔ Terminated; Low enrollment
Trial termination
August 10, 2022
Safety of Co-Administered CHI-554 and Alcohol
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Canopy Growth Corporation | Trial completion date: Jul 2022 ➔ Dec 2022 | Trial primary completion date: Jul 2022 ➔ Dec 2022
Trial completion date • Trial primary completion date
August 10, 2022
CBD in Postmenopausal Women With Osteopenia
(clinicaltrials.gov)
- P1 | N=2 | Active, not recruiting | Sponsor: Canopy Growth Corporation | Recruiting ➔ Active, not recruiting | N=60 ➔ 2
Enrollment change • Enrollment closed
1 to 5
Of
5
Go to page
1